healthcare.digital July 28, 2025
Lloyd Price

Executive Summary

This report serves as a comprehensive guide for digital health device innovators seeking to navigate the regulatory landscape established by the US Food and Drug Administration (FDA). The FDA is not merely regulating digital health; it is actively shaping and adapting its approach to foster innovation while ensuring the safety and effectiveness of these technologies.

This implies a dynamic regulatory environment that innovators must continuously monitor. Key resources, such as the Digital Health Center of Excellence (DHCoE), are highlighted as central points of contact and information. The report outlines critical regulatory pathways, delves into evolving areas like cybersecurity and real-world evidence, and provides a forward-looking perspective on the future of digital health regulation.

Introduction: FDA’s Commitment to Digital...

Today's Sponsors

Venturous
ZeOmega

Today's Sponsor

Venturous

 
Topics: Digital Health, FDA, Govt Agencies, Regulations, Technology
AI Model FDA-Cleared to Triage 14 Conditions
The Promise And Perils Of FDA’s New ‘Plausible Mechanism’ Pathway (Part 2)
FDA Updates Two Digital Health Final Guidance Documents
FDA in Flux — January 2026 Newsletter
The Promise And Perils Of FDA’s New ‘Plausible Mechanism’ Pathway (Part 1)

Share Article